title: Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction.
abstract: Hypoxia is an important contributor to the heterogeneity of the microenvironment of solid tumors and is a significant environmental stressor that drives adaptations which are essential for the survival and metastatic capabilities of tumor cells. Critical adaptive mechanisms include altered metabolism, pH regulation, epithelial-mesenchymal transition, angiogenesis, migration/invasion, diminished response to immune cells and resistance to chemotherapy and radiation therapy. In particular, pH regulation by hypoxic tumor cells, through the modulation of cell surface molecules such as extracellular carbonic anhydrases (CAIX and CAXII) and monocarboxylate transporters (MCT-1 and MCT-4) functions to increase cancer cell survival and enhance cell invasion while also contributing to immune evasion. Indeed, CAIX is a vital regulator of hypoxia mediated tumor progression, and targeted inhibition of its function results in reduced tumor growth, metastasis, and cancer stem cell function. However, the integrated contributions of the repertoire of hypoxia-induced effectors of pH regulation for tumor survival and invasion remain to be fully explored and exploited as therapeutic avenues. For example, the clinical use of anti-angiogenic agents has identified a conundrum whereby this treatment increases hypoxia and cancer stem cell components of tumors, and accelerates metastasis. Furthermore, hypoxia results in the infiltration of myeloid-derived suppressor cells (MDSCs), regulatory T cells (Treg) and Tumor Associated Macrophages (TAMs), and also stimulates the expression of PD-L1 on tumor cells, which collectively suppress T-cell mediated tumor cell killing. Therefore, combinatorial targeting of angiogenesis, the immune system and pH regulation in the context of hypoxia may lead to more effective strategies for curbing tumor progression and therapeutic resistance, thereby increasing therapeutic efficacy and leading to more effective strategies for the treatment of patients with aggressive cancer.
authors.affiliation: Department of Integrative Oncology, British Columbia Cancer Research Centre Vancouver, BC, Canada.
authors.forename: Paul C
authors.initials: PC
authors.lastname: McDonald
authors.affiliation: Department of Integrative Oncology, British Columbia Cancer Research Centre Vancouver, BC, Canada.
authors.forename: Shawn C
authors.initials: SC
authors.lastname: Chafe
authors.affiliation: Department of Integrative Oncology, British Columbia Cancer Research CentreVancouver, BC, Canada; Department of Biochemistry and Molecular Biology, University of British ColumbiaVancouver, BC, Canada.
authors.forename: Shoukat
authors.initials: S
authors.lastname: Dedhar
keywords: angiogenesis; carbonic anhydrase IX; hypoxia; immune checkpoint inhibitors; monocarboxylate transporter; tumor microenvironment